41 completed. 41 Phase 1, 9 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 41 | Completed 41 |
| Phase 2 | 9 | Completed 9 |
Follow Nausea: new trials by email Literature Review of Nausea trials Research Report on Nausea
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Phase I PK and Safety Study of Ondansetron Inhalation Powder LPI-1503, Matching Placebo of LPI-1503, IV Ondansetron - Postoperative Nausea and Vomiting | Phase 1 | Completed | Luxena Pharmaceuticals, Inc. | 24 | 2025-03-13 | 2026-03-27 |
| Effect of Magnesium Sulfate on Hemodynamics on Laparoscopic Cholecystectomy Patients Placebo, Magnesium - Hemodynamics Instability, Pain After Surgery | Phase 1 / Phase 2 | Completed | Ziauddin University | 60 | 2025-01-06 | 2026-09-02 |
| Pharmacokinetics and Bioequivalence of Doxylamine+Pyridoxine and Diclectin Under Fed Conditions in Healthy Volunteers Doxylamine + Pyridoxine, Diclectin - Nausea | Phase 1 | Completed | Valenta Pharm JSC | 28 | 2024-02-27 | 2025-07-11 |
| Effect of Glycopyrrolate on Nausea and Vomiting After ERCP Operation Glycopyrrolate, Anisodamine - Nausea and Vomiting | Phase 1 / Phase 2 | Completed | Jie Chen | 130 | 2023-10-01 | 2024-09-05 |
| Use of Aromatherapy in Conjunction With Physical/Occupational Therapy in an Acute Care Setting Lavender Oil, Mandarin Oil, Peppermint oil - Suffering, Physical, Nausea | Phase 1 | Completed | The University of Texas Health Science Center at San Antonio | 165 | 2022-05-16 | 2026-06-16 |
| Effect of Dexmedetomidine on Prevention of Postoperative Nausea and Vomiting in Children Dexamethasone, Ondansetron, Dexmedetomidine - Postoperative Nausea and Vomiting, Post Operative Pain | Phase 1 | Completed | Tanta University | 4 | 2021-10-27 | 2022-04-05 |
| Study to Assess Bioequivalence and Adhesion Properties Between Two Granisetron Transdermal Patches. Sancuso - Part 1, Sancuso - Part 2 - Healthy Volunteers | Phase 1 | Completed | Kyowa Kirin, Inc. | 134 | 2021-07-06 | 2024-06-14 |
| Olanzapine for the Prevention of Postoperative Nausea and Vomiting Placebo, 5 mg Olanzapine Tablets, 10 mg Olanzapine Tablets - Postoperative Nausea | Phase 1 / Phase 2 | Completed | Amani Hassan Abdel-Wahab | 132 | 2021-03-15 | 2023-03-09 |
| The Effect of Cannabidiol on Lean Body Mass in Patients Receiving Chemotherapy Cannabidiol - Lean Body Mass, Cannabis | Phase 1 | Completed | University of Copenhagen | 32 | 2020-12-01 | 2023-07-24 |
| Study to Evaluate Rate of Nausea in Healthy Premenopausal Female Subjects Treated With Single Dose of Bremelanotide Alone or With Zofran Bremelanotide, Zofran, Placebo - Nausea | Phase 1 | Completed | AMAG Pharmaceuticals, Inc. | 228 | 2019-06-17 | 2022-04-04 |
| Study of APD421 With and Without Ondansetron APD421, Placebo, Ondansetron - Postoperative Nausea and Vomiting | Phase 1 | Completed | Acacia Pharma Ltd | 30 | 2018-07-17 | 2018-10-01 |
| Study of Granisetron Hydrochloride Nasal Spray (GNS) in Healthy Volunteers GNS Spray 0.5mg, GNS Spray 1.0mg, GNS Spray 2.0mg - Cancer | Phase 1 | Completed | Maxinase Life Sciences Ltd. | 50 | 2015-09-01 | 2016-01-08 |
| A Study in Opioid-Experienced, Non-Dependent Recreational Drug Users to Determine the Abuse Potential and Safety of CL-108 Tablets Administered Via the Oral Route CL-108, M366, Placebo - Pain, Nausea | Phase 1 | Completed | Charleston Laboratories, Inc | 40 | 2015-06-01 | 2019-10-14 |
| Feasibility Study of Exenatide by Continuous Subcutaneous Infusion Exenatide - Obesity | Phase 1 | Completed | GlaxoSmithKline | 10 | 2013-05-16 | 2017-10-19 |
| How Pregnant Women and Their Babies Metabolize Ondansetron Compared to a Group of Non-pregnant Women Ondansetron - Postoperative Nausea | Phase 1 / Phase 2 | Completed | Stanford University | 100 | 2013-01-01 | 2015-06-01 |
| Acupuncture Treatment for Gastroparesis: a Pilot Study Acupuncture for gastroparesis, Acupuncture for musculoskeletal pain - Gastroparesis, Nausea | Phase 1 / Phase 2 | Completed | Johns Hopkins University | 20 | 2011-11-01 | 2016-09-02 |
| To Investigate the Effect of Intravenous Ondansetron on Cardiac Conduction as Compared to Placebo and Moxifloxacin in Healthy Adult Subjects ondansetron, moxifloxacin, saline - Nausea and Vomiting, Chemotherapy-Induced | Phase 1 | Completed | GlaxoSmithKline | 60 | 2011-08-16 | 2017-11-13 |
| 10% Carbohydrate Drink for Preventing Post-operative Nausea and Vomiting (PONV) After Spinal Morphine 10% carbohydrate drink - Nausea and Vomiting, Postoperative | Phase 1 | Completed | Mahidol University | 120 | 2011-02-01 | 2013-07-19 |
| Transcutaneous Electroacupuncture for Gastroparesis TEA, Sham-TEA - Diabetic Gastroparesis | Phase 1 | Completed | Transtimulation Research, Inc | 26 | 2010-03-01 | 2017-05-01 |
| Safety Study of a Rotavirus Vaccine (Rotavin-M1) Among Healthy Adults Rotavin - Diarrhea, Vomit | Phase 1 | Completed | National Institute of Hygiene and Epidemiology, Vietnam | 29 | 2009-08-01 | 2016-07-04 |
Showing 20 of 41. Sign in to see all of them.
Vomiting (23) · Postoperative Nausea and Vomiting (11) · Pain (3) · Anorexia (2) · Gastroparesis (2) · Neoplasms (2) · Abdominal Pain (1) · Appetitive Behavior (1) · Brain Neoplasms (1) · Breast Neoplasms (1) · Cachexia (1) · Diarrhea (1) · Dysgeusia (1) · Emergence Delirium (1)
Pathological Conditions, Signs and Symptoms (41) · Signs and Symptoms (41) · Signs and Symptoms, Digestive (41) · Pathologic Processes (11) · Postoperative Complications (11) · Vomiting (9) · Neurologic Manifestations (7) · Body Weight (3) · Digestive System Diseases (3) · Neoplasms (3) · Neoplasms by Site (3) · Nervous System Diseases (3) · Body Weight Changes (2) · Gastrointestinal Diseases (2)
Ondansetron (14) · casopitant (7) · Aprepitant (3) · Dexamethasone (2) · Granisetron (2) · Ketoconazole (2) · Tablets (2) · halofantrine (2) · Acupressure (1) · Acupuncture Therapy (1) · Cannabidiol (1) · Control Groups (1) · Cyclophosphamide (1) · Dexmedetomidine (1) · Docetaxel (1)
GlaxoSmithKline (9) · Forest Laboratories (3) · Merck Sharp & Dohme LLC (2) · Sandoz (2) · AMAG Pharmaceuticals, Inc. (1) · Acacia Pharma Ltd (1) · Amani Hassan Abdel-Wahab (1) · Charleston Laboratories, Inc (1) · Duke University (1) · Jie Chen (1) · Johns Hopkins University (1) · Kyowa Kirin, Inc. (1) · Luxena Pharmaceuticals, Inc. (1) · M.D. Anderson Cancer Center (1) · Mahidol University (1)
United States (21) · Canada (3) · Brazil (1) · China (1) · Denmark (1) · Egypt (1) · India (1) · Mexico (1) · Pakistan (1) · Russia (1) · Saudi Arabia (1) · Spain (1) · Taiwan (1) · Thailand (1) · Turkey (Türkiye) (1)
Eric Sicard, M.D. (3) · Soran Hong, M.D. (2) · Agop Y. Bedikian, MD (1) · Amani H Abdel-wahab, MD (1) · Anh D Dang, PhD (1) · Bernard P Schachtel, M.D (1) · Bianca Gonzales, OTR, CNT, EdD, MOT (1) · Christine M. Walko, PharmD, BCOP (1) · David R. Drover, MD (1) · Deborah H Allen, MSN, RN, CNS, FNP-BC, AOCNP (1) · Dr Asma A Salam, MBBS, FCPS (1)
PMID 17513629, PMID 19205754, PMID 19617379, PMID 20220045, PMID 20579837, PMID 22096279, PMID 22245954, PMID 22520120, PMID 23904932, PMID 25670522, PMID 25885838, PMID 26160357, PMID 31303716, PMID 31862004, PMID 31913911, PMID 32839657, PMID 40856942
2008 (1), P30CA016086 (1), R43AT004489 (1)